Clinical Trials Directory

Trials / Completed

CompletedNCT04354051

The Nitrite and Coronary Flow Study

The Vascular Effects of Nitrite on Coronary Flow Under Normoxia and Hypoxia

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University of East Anglia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is a pharmacodynamic proof of concept study investigating the physiological effects of systemic infusion of nitrite on coronary blood flow using MRI.

Detailed description

This is a healthy volunteer, proof of concept study. The participant will have blood taken and this will be analysed for baseline levels of nitrate, nitrite and nitroso species. They will then have a baseline MRI to assess coronary flow in normoxia. Next, hypoxia will be induced using 12% oxygen/88% nitrogen. The participant will then have a baseline MRI to assess coronary flow in hypoxia (3 breath-hold image captures). After all baseline images have been captured, the investigators will commence an intravenous nitrite sodium infusion, dose 70μmol, of 5 minute duration (14μmol /min-1). At the 5th minute, the participant have a further MRI image to assess coronary flow with the intervention in normoxia (3 breath-hold image captures). A 10-minute washout will follow (with the half-life of nitrite being documented as 110 seconds). There will be optional repeat 3 breath-hold image captures at 5 minutes and at 10 minutes. Next hypoxia will be induced using 12% oxygen/88% nitrogen again. The investigators will commence a second intravenous nitrite sodium infusion, dose 70μmol, 5 minute duration (14μmol /min-1). At the 5th minute, the participant will have a further MRI image to assess coronary flow with the intervention in hypoxia (3 breath-hold image captures). At the end of the study the participant will have blood taken and this will be analysed for repeat levels of nitrate, nitrite and nitroso species. All interventions will be performed by fully trained and competent medical staff.

Conditions

Interventions

TypeNameDescription
DRUGSodium NitriteIntravenous nitrite sodium infusion, dose 70μmol, of 5 minute duration (14μmol /min-1).

Timeline

Start date
2018-07-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2020-04-21
Last updated
2020-04-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04354051. Inclusion in this directory is not an endorsement.